Skip to main content

Water, Environmental Surveillance and Molecular Epidemiology of Poliovirus in India

  • Chapter
  • First Online:
Water and Health

Abstract

Poliomyelitis has appeared in epidemic form, become endemic on a global scale and has been reduced to near elimination, all within the span of documented medical history. Environmental surveillance of poliovirus (PV) means monitoring of PV transmission in human populations by examining environmental specimens supposedly contaminated by human faeces. The rationale for surveillance is based on the fact that PV-infected individuals, whether presenting with disease symptoms or not, shed large amounts of PV in the faeces for several weeks. As the morbidity: infection ratio of PV infection is very low, this fact contributes to the sensitivity of PV surveillance, which under optimal conditions can be better than that of the standard acute flaccid paralysis (AFP) surveillance. The World Health Organization (WHO) has included environmental surveillance of PV in the new Strategic Plan of the Global Polio Eradication Initiative for years 2010–2012 to be increasingly used in PV surveillance, supplementing AFP surveillance.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Andrus JK, Thapa AB, Withana N et al (2001) A new paradigm for international disease control: lessons learned from polio eradication in Southeast Asia. Am J Public Health 91:146–150

    Article  CAS  Google Scholar 

  • Barrett S (2009) Polio eradication: strengthening the weakest links. Health Aff (Millwood) 28:1079–1090

    Article  Google Scholar 

  • Blomqvist S, Savolainen C, Laine P, Hirttio P, Lamminsalo E, Pentilla E et al (2004) Characterisation of a highly evolved vaccine derived poliovirus type 3 isolated from sewage in Estonia. J Virol 78:4876–4883

    Article  CAS  Google Scholar 

  • Blume S, Geesink I (2000) A brief history of polio vaccines. Science 288:1593–1594

    Article  CAS  Google Scholar 

  • Blume SS (2005) Lock in, the state and vaccine development: lessons from the history of the polio vaccines. Res Policy 34:159–173

    Article  Google Scholar 

  • Buttinelli G, Donati V, Fiore S et al (2003) Nucleotide variation in sabin type 2 poliovirus from an immunodeficient patient with poliomyelitis. J Gen Virol 82:79–91

    Google Scholar 

  • Centers for Disease Control and Prevention (2001) Circulation of a type 2 vaccine-derived poliovirus-Egypt, 1982–1993. Morb Mortal Wkly Rep 50(41–42):51

    Google Scholar 

  • Centers for Disease control and Prevention (2002) Progress towards global eradication of poliomyelitis, 2001. Morb Mortal Wkly Rep 51:253–256

    Google Scholar 

  • De Jesus NH (2007) Epidemics to eradication: the modern history of poliomyelitis. Virol J 4:70

    Article  Google Scholar 

  • Divizia M, Palombi L, Buonomo E, Donia D, Ruscio V, Equestre M et al (1999) Genomic characterization of human and environmental polioviruses isolated in Albania. Appl Environ Microbiol 65:3534–3539

    CAS  Google Scholar 

  • Dove A (2001) Paralytic poliomyelitis returns to the Western Hemisphere. PICO News, Caribbean Outbreak

    Google Scholar 

  • Estı′variz CF, Molna′r Z, Venczel L et al (2011) Paralytic poliomyelitis associated with sabin monovalent and bivalent oral polio vaccines in Hungary. Am J Epidemiol 174:316–325

    Google Scholar 

  • Friedrich F (2000) Genomic modifications in oral poliovirus vaccine strains after multiplication in humans and implications for the eradication of poliovirus. Acta Virol 44:109–117

    CAS  Google Scholar 

  • Georgopoulou A, Markoulatos P, Spyrou N, Vamvakopoulos NC (2000) Improved genotyping vaccine and wild-type poliovirus strains by restriction fragment length polymorphism analysis: clinical diagnostic implications. J Clin Microbiol 38:4337–4342

    CAS  Google Scholar 

  • Ghendon Y, Robertson SE (1994) Interrupting the transmission of wild polioviruses with vaccines: immunological considerations. Bull World Health Organ 72:973–983

    CAS  Google Scholar 

  • Grassly NC, Jafari H, Bahl S et al (2009) Mucosal immunity after vaccination with monovalent and trivalent oral poliovirus vaccine in India. J Infect Dis 200:794–801

    Article  Google Scholar 

  • Heymann DL, Sutter RW, Aylward RB (2006a) A vision of a world without polio: the OPV cessation strategy. Biologicals 34(2):75–79

    Article  Google Scholar 

  • Heymann DL, Sutter RW, Aylward RB (2006b) Polio eradication: interrupting transmission, towards a polio-free world. Future Virol 1:181–188

    Article  Google Scholar 

  • Horie H, Yoshida H, Matsuura K, Miyazawa M, Wakabayashi K, Nomoto A, Hashizume S (2002) Isolation of vaccine-derived type 1 polioviruses displaying similar properties to virulent wild strain Mahoney from sewage in Japan. J Med Virol 68:445–451

    Article  Google Scholar 

  • Hovi T, Lindholm N, Savolainen C, Stenvik M, Burns C (2004) Evolution of wild type 1 poliovirus in two healthy siblings excreting the virus over a period of 6 months. J Gen Virol 85:369–377

    Article  CAS  Google Scholar 

  • John T, Jain H, Ravishankar K et al (2011) Monovalent type 1 oral poliovirus vaccine among infants in India: report of two randomized double-blind controlled clinical trials. Vaccine 5:5793–5801

    Article  Google Scholar 

  • Kaura G, Abraham T (2012) Polio eradication: a complex end game. BMJ 344:e2398

    Article  Google Scholar 

  • Kew OM, Sutter RW, Nottay BK et al (1998) Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient. J Clin Microbiol 36:3893–2899

    Google Scholar 

  • Kew OM, Wright PF, Agol VI (2004) Circulating vaccine-derived polioviruses: current state of knowledge. Bull World Health Organ 82:16–23

    Google Scholar 

  • Martin J, Ferguson GL, Wood DJ, Minor PD (2000) The vaccine origin of the 1968 epidemic of type 3 poliomyelitis in Poland. Virology 278:42–49

    Article  CAS  Google Scholar 

  • Martin J (2011) Detection and characterization of polioviruses. Methods Mol Biol (Cliffton) 665:233

    Google Scholar 

  • Modlin JF (2010) The bumpy road to polio eradication. N Engl J Med 362:2346–2349

    Article  CAS  Google Scholar 

  • Mukherji WCS, Jindal LCAK, Singh BZ et al (2005) Polio eradication in India: myth or reality. Med J Arm Forces Ind 61:364–366

    Article  Google Scholar 

  • Mulders MN, Reimerink JHJ, Stenvik M, Alaeddinoglu I, van der Avoort HGAM et al (1999) A sabin vaccine-derived field isolate of poliovirus type 1 displaying aberrant phenotypic and genetic features, including a deletion in antigenic site. J Gen Virol 80:907–916

    CAS  Google Scholar 

  • Nathanson N (2008) The pathogenesis of poliomyelitis: what we don’t know. Adv Virus Res 71:1–50

    Article  CAS  Google Scholar 

  • Nwachuku N, Gerba CP (2006) Health risks of enteric viral infections in children. Rev Environ Contam Toxicol 186:1–56

    Article  Google Scholar 

  • Kew O (2012) Reaching the last one per cent: progress and challenges in global polio eradication. Curr Opin Virol 2:188–198

    Article  Google Scholar 

  • Paul Y (2007) Role of genetic factors in polio eradication: new challenge for policy makers. Vaccine 25:8365–8371

    Article  Google Scholar 

  • Pelczar MJ Jr, Chan ECS, Krieg NR (1993) Microbiology: concepts and applications. McGraw-Hill Inc., New York 698

    Google Scholar 

  • Racaniello VR (2006) One hundred years of poliovirus pathogenesis. Virology 344:9–16

    Article  CAS  Google Scholar 

  • Rousset D, Rakoto-Andrianarivelo M, Razafindratsimandresy R et al (2003) Recombinant vaccine-derived poliovirus in Madagascar. Emerg Infect Dis 9:885–887

    Article  Google Scholar 

  • Sabin AB (1956) Pathogenesis of poliomyelitis; reappraisal in the light of new data. Science 123:1151–1157

    Article  CAS  Google Scholar 

  • Sathyamala C, Mittal O, Dasgupta R et al (2005) Polio eradication initiative in India: deconstructing the GPEI. Int J Health Serv 2:361–383

    Article  Google Scholar 

  • Shulman LM, Manor J, Handsher R, Delpeyroux F, MacDonough MJ, Halmut T et al (2000) Molecular and antigenic characterisation of a highly evolved derivative of the type 2 oral polio vaccine strain isolated from sewage in Israel. J Clin Microbiol 38:3729–3734

    CAS  Google Scholar 

  • Sutter RW, Prevots DR (1994) Vaccine-associated paralytic poliomyelitis among immunodeficient persons. Infect Med 11:426–438

    Google Scholar 

  • Sutter RW, Tangermann RH, Aylward RB et al (2001) Poliomyelitis eradication: progress, challenges for the end game, and preparation for the post-eradication era. Infect Dis Clin North Am 15:41–64

    Article  CAS  Google Scholar 

  • Vashishtha VM (2009) Polio eradication in India: need for caution. Indian J Pediatr 76:757

    Google Scholar 

  • Wood DJ, Sutter RW, Dowdle WR (2000) Stopping poliovirus vaccination after eradication: issues and challenges. Bull World Health Organ 78:347–357

    CAS  Google Scholar 

  • Wood N, Thorley B (2003) Viewpoint towards global poliomyelitis eradication: the successes and challenges for a developed country. J Paediatr Child Health 39:647–650

    Article  CAS  Google Scholar 

  • World Health Organization and UNICEF (2010) Progress on sanitation and drinking water: 2010 Update

    Google Scholar 

  • World Health Organization (2000) Outbreak news. Wkly Epidemiol Rec 75:397–399

    Google Scholar 

  • World Health Organization (2002) Manual for the virological investigation of poliomyelitis. World Health Organization (WHO/EPI/GEN/02.1), Geneva

    Google Scholar 

  • World Health Organization (2003a) OPV virus circulation and evolution investigated in New Zealand. Polio Lab Netw Quaterly Update 9:2–3

    Google Scholar 

  • World Health Organization (2003b) Progress towards the global eradication of poliomyletis, 2002. Wkly Epidemiol Rec 78:138–144

    Google Scholar 

  • World Health Organization (2004) Manual for the virological investigation of poliomyletis. World Health Organization (WHO/EPI/GEN/04), Geneva

    Google Scholar 

  • Yang CF, Naguib T, Yang SJ et al (2003) Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983–1993. J Virol 77:8366–8377

    Article  CAS  Google Scholar 

  • Yoshida H, Horie H, Matsuura K, Kitamura T, Hashizumi S, Miyamura T (2002) Prevalence of vaccine-derived polioviruses in the environment. J Gen Virol 83:1107–1111

    CAS  Google Scholar 

  • Zaoutis T, Klein JD (1998) Enterovirus infections. Pediatr Rev 19:183–191

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tapan N. Dhole .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer India

About this chapter

Cite this chapter

Dhole, T.N., Chatterjee, A. (2014). Water, Environmental Surveillance and Molecular Epidemiology of Poliovirus in India. In: Singh, P., Sharma, V. (eds) Water and Health. Springer, New Delhi. https://doi.org/10.1007/978-81-322-1029-0_2

Download citation

Publish with us

Policies and ethics